These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11185738)

  • 1. Recent progress in the genetics of incontinentia pigmenti (Bloch-Sulzberger syndrome).
    Shastry BS
    J Hum Genet; 2000; 45(6):323-6. PubMed ID: 11185738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetics of incontinentia pigmenti.
    Gorski JL; Burright EN
    Semin Dermatol; 1993 Sep; 12(3):255-65. PubMed ID: 8105861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cosmids map two incontinentia pigmenti type 1 (IP1) translocation breakpoints to a 180-kb region within a 1.2-Mb YAC contig.
    Gorski JL; Bialecki MD; McDonald MT; Massa HF; Trask BJ; Burright EN
    Genomics; 1996 Jul; 35(2):338-45. PubMed ID: 8661147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder.
    Ehrenreich M; Tarlow MM; Godlewska-Janusz E; Schwartz RA
    Cutis; 2007 May; 79(5):355-62. PubMed ID: 17569396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Finnish incontinentia pigmenti (IP) families with recombinations with the IP loci at Xq28 and Xp11.
    Hydén-Granskog C; Salonen R; von Koskull H
    Hum Genet; 1993 Mar; 91(2):185-9. PubMed ID: 8096494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incontinentia pigmenti in a male patient].
    Burkhardt D; Schuffenhauer S; Peter RU; Walther JU; Ruzicka T
    Hautarzt; 1993 Mar; 44(3):153-6. PubMed ID: 8463096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.
    Culić V; Gabrić D; Puizina-Ivić N; Rozman K; Peterlin B; Pavelić J
    Coll Antropol; 2008 Dec; 32(4):1259-62. PubMed ID: 19149237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incontinentia pigmenti in a male infant].
    Vehring KH; Kurlemann G; Traupe H; Bonsmann G; Gerding H; Möllmann S; Hamm H
    Hautarzt; 1993 Nov; 44(11):726-30. PubMed ID: 8276592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incontinentia pigmenti (type 1) and X;5 translocation.
    Bitoun P; Philippe C; Cherif M; Mulcahy MT; Gilgenkrantz S
    Ann Genet; 1992; 35(1):51-4. PubMed ID: 1610121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage analysis in 16 families with incontinentia pigmenti.
    Jouet M; Stewart H; Landy S; Yates J; Yong SL; Harris A; Garret C; Hatchwell E; Read A; Donnai D; Kenwrick S
    Eur J Hum Genet; 1997; 5(3):168-70. PubMed ID: 9272741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti.
    Steffann J; Raclin V; Smahi A; Woffendin H; Munnich A; Kenwrick SJ; Grebille AG; Benachi A; Dumez Y; Bonnefont JP; Hadj-Rabia S
    Prenat Diagn; 2004 May; 24(5):384-8. PubMed ID: 15164415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incontinentia pigmenti in male patients.
    Pacheco TR; Levy M; Collyer JC; de Parra NP; Parra CA; Garay M; Aprea G; Moreno S; Mancini AJ; Paller AS
    J Am Acad Dermatol; 2006 Aug; 55(2):251-5. PubMed ID: 16844507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unstable pre-mutation may explain mosaic disease expression of incontinentia pigmenti in males.
    Traupe H; Vehring KH
    Am J Med Genet; 1994 Feb; 49(4):397-8. PubMed ID: 8160732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incontinentia pigmenti].
    Esholdt IH
    Nord Med; 1994; 109(2):58-60. PubMed ID: 8121791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of DNA sequences to a region within Xp11.21 between incontinentia pigmenti (IP1) X-chromosomal translocation breakpoints.
    Gorski JL; Burright EN; Harnden CE; Stein CK; Glover TW; Reyner EL
    Am J Hum Genet; 1991 Jan; 48(1):53-64. PubMed ID: 1985463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of incontinentia pigmenti.
    Curth HO; Warburton D
    Arch Dermatol; 1965 Sep; 92(3):229-35. PubMed ID: 11851242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age].
    Portaleone D; Taroni F; Micheli S; Moioli M; Pedrazzini A; Cognizzoli P; Carnelli V
    Minerva Pediatr; 2007 Jun; 59(3):255-65. PubMed ID: 17519871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
    Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
    Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two neonates with vesicular skin lesions due to incontinentia pigmenti].
    Winterberg DH; van Tijn DA; Smitt JH; Winterberg S; Vomberg PP
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2178-82. PubMed ID: 11727618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incontinentia pigmenti. A rare disease with many symptoms].
    Holmström G; Bergendal B; Hallberg G; Marcus S; Hallén A; Dahl N
    Lakartidningen; 2002 Mar; 99(12):1345-50. PubMed ID: 11998169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.